Revised Saudi Guide Addresses Frequent Questions On New Expedited Drug Registration Process
Executive Summary
The Saudi FDA has issued four revised guidelines, including one on its recently-launched expedited process for registering new drugs and biologics based on the product’s prior approval in the US and the EU.